Lorlatinib and Bevacizumab Activity in ALK-Rearranged Lung Cancers After Lorlatinib Progression

Choudhury, NJ; Young, RJ; Sellitti, M; Miller, A; Drilon, A

Drilon, A (corresponding author), Mem Sloan Kettering Canc Ctr, 22nd FI,545 E73rd St, New York, NY 10021 USA.

JCO PRECISION ONCOLOGY, 2020; 4 (): 1333

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索